Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response

Ketty Peris, F Fantini, A Greco, C Del Giovane, Am Cesinaro, M Venturini, C Zane, T Surrenti, Pg Calzavara Pinton

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Photodynamic therapy (PDT) is increasingly used in the treatment of basal cell carcinoma (BCC). However, scant information is available about the impact of both patient- and lesion-related characteristics on the effectiveness of therapy. Therefore, on the basis of the current data, it is difficult to draw clear-cut indications to use PDT for treatment of BCC in clinical practice.
Original languageEnglish
Pages (from-to)896-901
Number of pages6
JournalJournal of the European Academy of Dermatology and Venereology
Volume25
DOIs
Publication statusPublished - 2011

Keywords

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid
  • Carcinoma, Basal Cell
  • Extremities
  • Female
  • Head and Neck Neoplasms
  • Humans
  • Male
  • Middle Aged
  • Photochemotherapy
  • Photosensitizing Agents
  • Retrospective Studies
  • Sex Factors
  • Skin Neoplasms
  • Torso
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response'. Together they form a unique fingerprint.

Cite this